Genesco Inc. (GCO) posted second-quarter fiscal 2025 results, with a narrower-than-expected loss per share and sales beat. Quarterly results benefited from improved Journeys business and diversified product assortment. The Journeys business gained from the early back-to-school demand, which boosted comparable sales (comps). Its cost-saving program is on track to achieve a reduction in the range of $45-$50 million in the annualized run rate by the end of fiscal 2025.Shares of this Zacks Rank #1 (Strong Buy) ...